Last reviewed · How we verify
Artemether 20 mg-Lumefantrine 120 mg
Artemether 20 mg-Lumefantrine 120 mg is a Small molecule drug developed by University of Oxford. It is currently FDA-approved.
At a glance
| Generic name | Artemether 20 mg-Lumefantrine 120 mg |
|---|---|
| Sponsor | University of Oxford |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa (PHASE4)
- Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials (PHASE2, PHASE3)
- Safety of Antimalarials in the FIRst trimEster (PHASE3)
- A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines (PHASE3)
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs. (PHASE3)
- Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield (NA)
- ACT vs CQ With Tafenoquine for P. Vivax Mono-infection (PHASE4)
- Extended Duration Artemether-lumefantrine Treatment for Malaria in Children (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Artemether 20 mg-Lumefantrine 120 mg CI brief — competitive landscape report
- Artemether 20 mg-Lumefantrine 120 mg updates RSS · CI watch RSS
- University of Oxford portfolio CI
Frequently asked questions about Artemether 20 mg-Lumefantrine 120 mg
What is Artemether 20 mg-Lumefantrine 120 mg?
Artemether 20 mg-Lumefantrine 120 mg is a Small molecule drug developed by University of Oxford.
Who makes Artemether 20 mg-Lumefantrine 120 mg?
Artemether 20 mg-Lumefantrine 120 mg is developed and marketed by University of Oxford (see full University of Oxford pipeline at /company/university-of-oxford).
What development phase is Artemether 20 mg-Lumefantrine 120 mg in?
Artemether 20 mg-Lumefantrine 120 mg is FDA-approved (marketed).